Skip to main content

Hatchpak Cocci III (Canada)

This page contains information on Hatchpak Cocci III for veterinary use.
The information provided typically includes the following:
  • Hatchpak Cocci III Indications
  • Warnings and cautions for Hatchpak Cocci III
  • Direction and dosage information for Hatchpak Cocci III

Hatchpak Cocci III

This treatment applies to the following species:
Company: Boehringer Ingelheim Animal Health

Coccidiosis Vaccine

Live Oocysts

Hatchpak Cocci III Indications

This product has been shown to be effective for the vaccination of healthy chickens 1 day of age or older against coccidiosis due to E. maxima, E. acervulina, and/or E. tenella. The duration of immunity has not been established. For more information regarding efficacy and safety data, see

This vaccine contains the oocysts of Eimeria maxima, Eimeria acervulina, and Eimeria tenella.

Hatchpak Cocci III Caution

Administer only as recommended.

Use entire contents when first opened.

Do not mix with other products, except as specified on the label.

Do not vaccinate within 21 days of slaughter.

Inactivate unused contents before disposal.

Contains potassium dichromate as a preservative.

Storage Conditions

Store at 2 - 8°C (35 - 46°F). Do not freeze.


1. Do not open vaccine vial until ready to vaccinate.

2. Reconstitute vaccine at a rate of 21 to 30 mL per 100 chickens using non-chlorinated water. Dye may be added to monitor spray vaccination dispersal.

3. Administer a full dose to each chicken by spraying each box of 100 chickens with the appropriate volume of vaccine solution based on the dilution rate used to reconstitute (21 to 30 mL).


Do not vaccinate diseased chickens.

Vaccinate all chickens on the premises at one time.

Administer a minimum of one dose per chicken.

Avoid stress conditions during and following vaccination.

Do not place chickens in contaminated facilities.

Exposure to disease must be minimized as much as possible.

For veterinary use only.

In case of human exposure, contact a physician.

This vaccine is not recommended for use on chicks receiving a feed containing a coccidiostat or high levels of antibiotic.

Following vaccination, it may be necessary to use drugs for treatment of disease conditions other than coccidiosis. If such drugs, with a coccidiostat activity, are used during the first or second week post-vaccination of Boehringer Ingelheim’s Coccidiosis Vaccine, revaccination is recommended.


Boehringer Ingelheim’s vaccines have met the requirements of the USDA/CFIA in regard to safety, purity and potency.

Hatchpak Cocci III Caution

The capability of this vaccine to produce satisfactory results depends upon many factors including - but not limited to - conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual chickens and degree of field exposure. Therefore, directions for use should be followed carefully. The use of this vaccine is subject to applicable local and federal laws and regulations.


HATCHPAK® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH, used under license.

Manufactured by:

Boehringer Ingelheim Animal Health USA Inc., Gainesville, GA 30501 USA

VLN/PCN 124/1431.51

Distributed in Canada by:

Boehringer Ingelheim Animal Health Canada Inc., Burlington ON L7L 5H4

Product Codes COXY305K, COXY310K, COXY320K



Presentation: 10 x 10,000 doses.

CPN: 1182155.1

Customer Care No.:   1-800-567-1885
Technical Services No.:   1-877-565-5501
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-02-28